Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S P Geelen

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Infection and Immunity|August 24, 1999
Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor HC Neeleman, S P Geelen, P C Aerts, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2001
Pharmacokinetics of the protease inhibitor indinavir in human immunodeficiency virus type 1-infected childrenD M Burger, A M van Rossum, P W Hugen, et al.
The Journal of Infectious Diseases|December 7, 2000
Vascular endothelial growth factor in bacterial meningitis: detection in cerebrospinal fluid and localization in postmortem brainM van der Flier, G Stockhammer, G J Vonk, et al.
AIDS (London, England)|December 2, 1998
Early recovery of CD4+ T lymphocytes in children on highly active antiretroviral therapy. Dutch study group for children with HIV infectionsJ W Cohen Stuart, W A Slieker, G T Rijkers, et al.
The Journal of Pediatrics|June 6, 2000
Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: a multicenter study in the Netherlands. On behalf of the Dutch Study Group for Children with HIV-1 infectionsA M van Rossum, H G Niesters, S P Geelen, et al.
AIDS (London, England)|November 8, 2001
Therapeutic immune reconstitution in HIV-1-infected children is independent of their age and pretreatment immune statusA M van Rossum, H J Scherpbier, E G van Lochem, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Infection and Immunity|August 24, 1999
Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor HC Neeleman, S P Geelen, P C Aerts, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2001
Pharmacokinetics of the protease inhibitor indinavir in human immunodeficiency virus type 1-infected childrenD M Burger, A M van Rossum, P W Hugen, et al.
The Journal of Infectious Diseases|December 7, 2000
Vascular endothelial growth factor in bacterial meningitis: detection in cerebrospinal fluid and localization in postmortem brainM van der Flier, G Stockhammer, G J Vonk, et al.
AIDS (London, England)|December 2, 1998
Early recovery of CD4+ T lymphocytes in children on highly active antiretroviral therapy. Dutch study group for children with HIV infectionsJ W Cohen Stuart, W A Slieker, G T Rijkers, et al.
The Journal of Pediatrics|June 6, 2000
Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: a multicenter study in the Netherlands. On behalf of the Dutch Study Group for Children with HIV-1 infectionsA M van Rossum, H G Niesters, S P Geelen, et al.
AIDS (London, England)|November 8, 2001
Therapeutic immune reconstitution in HIV-1-infected children is independent of their age and pretreatment immune statusA M van Rossum, H J Scherpbier, E G van Lochem, et al.
Pageof 3